Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H23N3O |
Molecular Weight | 285.384 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC1CCC(CC1)C2=NC(=NO2)C3=CC=NC=C3
InChI
InChIKey=OAVLEYPTWABFLF-UHFFFAOYSA-N
InChI=1S/C17H23N3O/c1-2-3-4-13-5-7-15(8-6-13)17-19-16(20-21-17)14-9-11-18-12-10-14/h9-13,15H,2-8H2,1H3
Molecular Formula | C17H23N3O |
Molecular Weight | 285.384 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16517404Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24323890
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16517404
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24323890
PSN375963 is agonist of GPR119 receptor. Treatment of mice islet cells with PSN375963 stimulated insuline resistance.
Originator
Sources: http://www.google.tl/patents/WO2005061489A1
Curator's Comment: Aquired by OSI Pharmaceuticals
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q8TDV5 Gene ID: 139760.0 Gene Symbol: GPR119 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16517404 |
8.4 µM [EC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. | 2006 Mar |
|
Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice. | 2014 Apr |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24323890
In the model of insuline resistance, PSN375963 was administered to mice by intraperitoneal injection in combination with glucose. Dose of 0.1 umol/l/kg did not lead to statistically significant difference in AUC of plasma insulin.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16517404
Activity of PSN375963 towards GPR119 was measured in yeast fluorimetric assay and by increase of intracellular cAMP in HEK-OSGPR116 cells expressing GPR119. PSN375963 stimulates GPR119 with EC50 of 8.4 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:57:15 GMT 2023
by
admin
on
Sat Dec 16 17:57:15 GMT 2023
|
Record UNII |
C9M28M425E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C9M28M425E
Created by
admin on Sat Dec 16 17:57:15 GMT 2023 , Edited by admin on Sat Dec 16 17:57:15 GMT 2023
|
PRIMARY | |||
|
2875918
Created by
admin on Sat Dec 16 17:57:15 GMT 2023 , Edited by admin on Sat Dec 16 17:57:15 GMT 2023
|
PRIMARY | |||
|
PSN-375,963
Created by
admin on Sat Dec 16 17:57:15 GMT 2023 , Edited by admin on Sat Dec 16 17:57:15 GMT 2023
|
PRIMARY | |||
|
388575-52-8
Created by
admin on Sat Dec 16 17:57:15 GMT 2023 , Edited by admin on Sat Dec 16 17:57:15 GMT 2023
|
PRIMARY | |||
|
DTXSID201028459
Created by
admin on Sat Dec 16 17:57:15 GMT 2023 , Edited by admin on Sat Dec 16 17:57:15 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->LIGAND |
|